lobbying_activities: 2818689

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2818689	ecf1699f-cac4-4313-a7ec-e7dfbec1902f	Q2	SAM ACTION, INC.	401104337	SAM ACTION, INC.	2022	second_quarter	LAW	H.R.2093/S. 1028, STATES Act to legalize marijuana, appropriations amendments related to marijuana legalization, criminal justice reform related to marijuana, H.R.3884, MORE Act.	Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Natl Drug Control Policy (NDCP),SENATE,White House Office		10000	0	0	2022-07-14T09:38:25-04:00